NCT02869958: PANAME

Digital Action Plan for Asthma Attacks

Completed NA Last updated 4 December 2020

What this trial tests

NA trial testing Digital action plan for asthma exacerbations + Written action plan in Asthma in 280 participants. Completed in 29 April 2020.

Timeline

3 November 2016

Primary endpoint
29 April 2020

29 April 2020

Quick facts

Lead sponsor	Assistance Publique - Hôpitaux de Paris
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	280
Start date	3 November 2016
Primary completion	29 April 2020
Estimated completion	29 April 2020
Sites	2 locations across France

Drugs / interventions tested

• Digital action plan for asthma exacerbations + Written action plan
• Written action plan

Conditions studied

• Asthma — all drugs for Asthma →

Sponsor

Assistance Publique - Hôpitaux de Paris — full company profile →

Who can join

Adults 6 to 60, any sex, with Asthma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

It is recommended that patients with asthma owned a written action plan which must include the names, doses and dosing of the treatment they should take when acute respiratory symptoms occur.

Current written action plans must be short to be readily used (1 page) and, therefore, cannot fit all acute situations. Moreover, they may not be available where and when required.

The investigators sought that a digital action plan, available through Smartphone or tablet computer connected to the internet, could adequately provide suitable action plans according to the severity of the described exacerbation, and would be more easily available when useful.

The aim of the study is to study the effect of the use of a digital action plan for asthma exacerbation, on the frequency of unscheduled medical contacts (phone calls, visits to physicians or to emergency departments, hospitalizations) in children and in adults with asthma. The investigators hypothesized that the use of the digital action plan could reduce avoidable unscheduled visits due to mild or moderate exacerbations that could successfully be managed by the patient or his/her caregivers.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Digital Action Plan (Web App) for Managing Asthma Exacerbations: Randomized Controlled Trial.
   Beydon N, Taillé C, Corvol H, Valcke J, et al · · 2023 · cited 7× · PMID 37255277 · DOI 10.2196/41490